Dr. Deborah Wong, MD, PhD
Claim this profileUCLA / Jonsson Comprehensive Cancer Center
Area of expertise
Pancreatic Cancer
Deborah Wong, MD, PhD has run 4 trials for Pancreatic Cancer. Some of their research focus areas include:
Squamous Cell Carcinoma
Deborah Wong, MD, PhD has run 3 trials for Squamous Cell Carcinoma. Some of their research focus areas include:
Affiliated Hospitals
University Of California Los Angeles (UCLA)
UCLA / Jonsson Comprehensive Cancer Center
Clinical Trials Deborah Wong, MD, PhD is currently running
TAB004 + Toripalimab
for Solid Cancers
The primary objective is to assess the safety and tolerability of TAB004 as monotherapy and in combination with toripalimab in subjects with selected advanced solid malignancies, including lymphoma, and to evaluate the recommended Phase 2 dose. The secondary objectives are to: 1) describe the pharmacokinetic (PK) profile of TAB004 monotherapy and in combination with toripalimab and to describe the PK profile of toripalimab when administered with TAB004, 2) evaluate antitumor activity of TAB004 monotherapy and in combination with toripalimab; and 3) determine the immunogenicity of TAB004 monotherapy and in combination with toripalimab and to determine the immunogenicity of toripalimab when administered with TAB004. The exploratory objectives are to: 1) evaluate pharmacodynamic effects of TAB004 on its target receptor BTLA, as well as effects on the immune system; 2) evaluate biomarkers that may correlate with activity of TAB004 as monotherapy and in combination with toripalimab; 3) evaluate the utility of BTLA ligand, herpesvirus-entry mediator (HVEM), and additional exploratory biomarkers that could aid in selection of appropriate subjects for TAB004 monotherapy and in combination with toripalimab.
Recruiting
1 award
Phase 1
10 criteria
Pembrolizumab
for Leukoplakia
This trial studies how well pembrolizumab works in treating leukoplakia. Pembrolizumab helps the immune system fight cancer by blocking a protein that prevents immune cells from attacking cancer cells. The trial targets patients with leukoplakia, aiming to see if this medication can effectively treat this condition. Pembrolizumab is an immune checkpoint inhibitor that has been used in the treatment of various cancers, including non-small cell lung cancer, melanoma, and head and neck cancers.
Recruiting
1 award
Phase 2
More about Deborah Wong, MD, PhD
Clinical Trial Related
6 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Deborah Wong, MD, PhD has experience with
- Pembrolizumab
- Cetuximab
- FS118
- TAB004
- Toripalimab
- Rivoceranib
Breakdown of trials Deborah Wong, MD, PhD has run
Pancreatic Cancer
Squamous Cell Carcinoma
Head and Neck Cancers
Head and Neck Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Deborah Wong, MD, PhD specialize in?
Deborah Wong, MD, PhD focuses on Pancreatic Cancer and Squamous Cell Carcinoma. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Deborah Wong, MD, PhD currently recruiting for clinical trials?
Yes, Deborah Wong, MD, PhD is currently recruiting for 3 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Deborah Wong, MD, PhD has studied deeply?
Yes, Deborah Wong, MD, PhD has studied treatments such as Pembrolizumab, Cetuximab, FS118.
What is the best way to schedule an appointment with Deborah Wong, MD, PhD?
Apply for one of the trials that Deborah Wong, MD, PhD is conducting.
What is the office address of Deborah Wong, MD, PhD?
The office of Deborah Wong, MD, PhD is located at: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California 90095 United States. This is the address for their practice at the UCLA / Jonsson Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.